| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |